Liz Miller
Liz Miller
Elizabeth Sinclair Milleris a British physician, surgeon, campaigner and writer noted for her outspoken stance on mental health, and bipolar disorderin particular. Although she has a long history of television and radio appearances, she came to public prominence in Stephen Fry's Emmy Award-winning documentary The Secret Life of the Manic Depressive in 2006. In 2008 she was voted Mind Champion of the Year by public poll...
keys anxiety missing
Almost all negative moods are missing one key element - calm. By learning calm, you learn to deal with difficult areas. Calm allows us to achieve what we want, without being overwhelmed by anxiety.
double expect fourth high low months nicer picks quarter single six
We expect the fourth quarter to be pretty dismal, and the first six months of 2002 could be unexciting. Then it picks up from there. On a comparative basis, it'll look nicer than this year. I think we'll be up high single to a low double digits.
evidence expect further labor looking numbers release tight
We're going to be looking for further evidence that it is a tight (labor) market, ... Or there has been some release on that pressure, but I think today's numbers tell us we had better expect the worst.
benefit kids
They all will benefit from more kids in school,
balance bit case concern couple earnings great hearing investment next patent percent pipeline project recent solid
Merck, too, is down on recent news, down in this case from around 85, ... You keep hearing a little bit of concern about their patent expirations over the next two years. Those are very real. But most of analysts say their drug pipeline is pretty solid and their earnings are project to be some 15-to-18 percent for the next couple of years. This is a great investment with which to balance out your high-tech holdings.
morning
getting up in the morning is for jerks.
benefit couple finally high ignored last management radar saw screen seeing several start stock totally tremendous year
Gillette has been off everyone's radar screen for a couple years. New management last year -- we saw (it) in the first-quarter numbers, finally seeing some benefit of that, ... Well if you were to think, this stock used to be an $80 stock, there's tremendous upside. Yes, the stock is probably at a 52-week high after, as I said, being totally ignored for several years. So I think what you're really seeing is the start of an uptrend.
changed exposure favorites great improving internal parts reasonably relatively stock valued
From a valuation standpoint, this is one of my favorites at the moment. I think they have changed around a lot of the internal issues, ... It's not that I think they're all the way there, but I think they know what they have to do. The stock is relatively reasonably valued historically and it's a great way to have exposure to all parts of an improving market.
amazing behavior benefits change clearly entry great half held higher less level likely market recommend stock watch year
If we do see any slowdown in the market or any back-up from rates, the higher end purchaser is the one less likely to change their behavior and Tiffany benefits from that, ... Tiffany clearly has had an amazing run, so far, this year. We've held it for about year and a half now. I don't recommend this level at -- as entry point, but it's a great stock to watch and look for an entry point.
beverages bottled earnings food good great lately latest media money people pepsi seasons snack stable telling unsure water
Similarly, I think beverages have been a great place to be. Pepsi has been doing everything right lately and I think that's a good place to put some new money if people are unsure during these earnings seasons where to go, ... Stable business, great snack food and now the latest media is telling us they're going to really do great in water -- bottled water.
aging approved baby cycle explain generation great last next past patient product sort sure time week
Medtronic I think is a great way to play sort of everyone getting older, as they say, the aging baby boom. They have a new product out that was approved last winter. It does two different things. An implantable device, and I'm not sure I'd explain it all well enough, but it's the next generation from the old pacemakers. And they have just over the past week implanted that for the first time in a patient and that's a whole great new product cycle about to start.
business decent defense definitely favorite general review sector seeing stocks
One thing we are seeing is decent review in spending. The defense sector is definitely benefiting from that. Their business is improving, their stocks are doing well. My favorite is General Dynamics.
action again bit catalyst certainly days excuse few focused good iraq last latest military news portion rival shots today
We just don't have a good catalyst in these last few days to end us on an up note. The latest excuse is focused again on any military action in Iraq -- but certainly that's not new news and some portion of that should be discounted in this market. So, it's just these rival shots from different corporations -- today we get a little bit of better news.
location natural
We thought the TCC was a natural location